What is the role of susceptibility testing in the treatment of mycobacterium chelonae infection?

Updated: Dec 20, 2018
  • Author: Alfred Scott Lea, MD; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

Susceptibility testing should be performed on all isolates to guide treatment. General susceptibility results reported in the ATS guidelines are as follows [25] :

  • Tobramycin - 100%

  • Clarithromycin - 100%

  • Linezolid - 50-90%

  • Imipenem - 60%

  • Amikacin - 50%

  • Doxycycline - 25%

  • Ciprofloxacin - 20%

In vitro susceptibility testing may not correlate with in vivo results and vice versa.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!